Figure 1

Proportion of a) ART-naïve and b) pretreated but PI-naïve patients with HIV-1 RNA < 50 copies/mL and < 400 copies/mL at baseline (BL) and week 96 (w96).
Proportion of a) ART-naïve and b) pretreated but PI-naïve patients with HIV-1 RNA < 50 copies/mL and < 400 copies/mL at baseline (BL) and week 96 (w96).